Low-dose Hydroxychloroquine Therapy and Mortality in Hospitalized Patients with COVID-19: A Nationwide Observational Study of 8075 Participants
OPEN International journal of antimicrobial agents | 28 Aug 2020
L Catteau, N Dauby, M Montourcy, E Bottieau, J Hautekiet, E Goetghebeur, S van Ierssel, E Duysburgh, H Van Oyen, C Wyndham-Thomas and D Van Beckhoven
Hydroxychloroquine (HCQ) has been largely used and investigated as therapy of COVID-19 across various settings, at total dose usually ranging from 2400 mg to 9600 mg. In Belgium, off-label use of low-dose HCQ (2400 mg in total over five days) was recommended for hospitalized patients with COVID-19.
* Data courtesy of Altmetric.com